Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Amantadine reduces weight gain from olanzapine treatment

Feb. 15, 2005

Cerebral blood flow unaltered by BIBN-4096BS in healthy subjects

Feb. 15, 2005

Controlled-release paroxetine reported safe and effective in panic disorder

Feb. 15, 2005

Novel cannabinoid CB1 receptor agonists claimed by AstraZeneca

Feb. 15, 2005

NeuroMolecular receives award to support memantine development efforts

Feb. 15, 2005

Metabotropic glutamate (mGluR5) receptor antagonists described in patent literature

Feb. 14, 2005

XP-13512 enters phase IIb study for restless legs syndrome

Feb. 14, 2005

Phase II study of Durect's postoperative pain relief depot product progresses

Feb. 14, 2005

Positive phase III results for Nuvigil

Feb. 14, 2005

Pharmacokinetic study of TRANSDUR-based sufentanil patch completes dosing

Feb. 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...